Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study

J Dermatolog Treat. 2023 Dec;34(1):2199108. doi: 10.1080/09546634.2023.2199108.

Authors

Luciano Ibba^{1

2}, Luigi Gargiulo^{1

2}, Angela Alfano^{1

2}, Ruggero Cascio Ingurgio^{1

2}, Alessandra Narcisi¹, Antonio Costanzo^{1

2}, Mario Valenti^{1

2}

Affiliations

¹ Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.
² Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

PMID: 37010456
DOI: 10.1080/09546634.2023.2199108

No abstract available

Keywords: Biologics; palmoplantar; psoriasis; real-life.

Publication types

Letter

MeSH terms

Humans
Interleukin-17 / immunology
Interleukin-23 / metabolism
Psoriasis* / drug therapy
Retrospective Studies

Substances

Interleukin-23
Interleukin-17